Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway
Xiayun Ni, Xiaojun Feng, Zhihua Wang, Yang Zhang, Peter J. Little, Yang Cao, Suowen Xu, Liqin Tang, Jianping Weng
Topics & Concepts
EmpagliflozinLiraglutideMedicineEndocrinologyInternal medicinePharmacologyType 2 diabetesDiabetes mellitusDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer